Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].

× No keyword cloud information.

22 in total

1. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.

Authors: B J Gallay; S Ahmad; L Xu; B Toivola; R C Davidson
Journal: Am J Kidney Dis Date: 2001-04 Impact factor: 8.860

2. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.

Authors: Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle; Robert M Kisabeth; Stephen T Turner
Journal: Clin Chem Date: 2002-11 Impact factor: 8.327

3. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.

Authors: D Hirohara; K Nomura; T Okamoto; M Ujihara; K Takano
Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958

4. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors: C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal: J Clin Endocrinol Metab Date: 2000-05 Impact factor: 5.958

5. Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

Authors: A M Sawka; W F Young; G B Thompson; C S Grant; D R Farley; C Leibson; J A van Heerden
Journal: Ann Intern Med Date: 2001-08-21 Impact factor: 25.391

6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors: B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal: N Engl J Med Date: 1999-09-02 Impact factor: 91.245

[Primary hyperaldosteronism: should we pose its systematic detection at health centres?].

1. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.

2. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.

3. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.

4. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

5. Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

7. Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy.

Review 8. A review of the medical treatment of primary aldosteronism.

9. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.

Review 10. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.